A real-world observational study characterizing patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) treated with or without androgen receptor pathway inhibitors (ARPIs). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results